Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (66)	3/28/2006 6:18:15 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 70

This is primo space, anywhere in the world. It certainly beats Chatsworth. Amgen plans big expansion in Seattle Tuesday March 28, 6:06 pm ET Amgen will add up to 550,000 square feet of new office and lab space on its site at Pier 89 in Seattle that will have the capacity to house up to 750 new employees. The California-based biotech said it will add six new buildings on its 40-acre site, and construction is expected to begin this fall, according to company spokeswoman Carol Pawlak. She said 150 new jobs will be created this year. Three new lab buildings, a facilities building, an office building and a new warehouse are being planned, with construction estimated to take four years. About 300,000 square feet of empty warehouse space at the site will be torn down. She added there's no estimate on what the new buildings will cost. Amgen currently has 750 employees at the site. "Were excited to be expanding in Seattle. It helps create a more vibrant biotech hub for the region," Pawlak said. Published March 28, 2006 by the Puget Sound Business Journal